Promoter Polymorphisms of ST3GAL4 and ST6GAL1 Genes and Associations with Risk of Premalignant and Malignant Lesions of the Cervix |
de los Angeles Rivera-Juarez, Maria
(Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social)
Rosas-Murrieta, Nora Hilda (Centro de Quimica, Instituto de Ciencias, Benemerita Universidad Autonoma de Puebla) Mendieta-Carmona, Victoriano (Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) Hernandez-Pacheco, Raquel Esneidy (Facultad de Medicina, Benemerita Universidad Autonoma de Puebla) Zamora-Ginez, Irma (Facultad de Medicina, Benemerita Universidad Autonoma de Puebla) Rodea-Avila, Carlos (Hospital de Oncologia, UMAE Hospital de Oncologia. Centro Medico Nacional Siglo XXI) Apresa-Garcia, Teresa (Unidad de Investigacion en Enfermedades Oncologicas, UMAE Hospital de Oncologia. Centro Medico Nacional Siglo XXI) Garay-Villar, Onix (Servicio de Radioterapia, Area de Braquiterapia, UMAE Hospital de Oncologia. Centro Medico Nacional Siglo XXI) Aguilar-Lemarroy, Adriana (Division de Inmunologia, Centro de Investigacion Biomedica de Occidente (CIBO)) Jave-Suarez, Luis Felipe (Division de Inmunologia, Centro de Investigacion Biomedica de Occidente (CIBO)) Diaz-Orea, Maria Alicia (Facultad de Medicina, Benemerita Universidad Autonoma de Puebla) Milflores-Flores, Lorena (Escuela de Biologia, Benemerita Universidad Autonoma de Puebla) Reyes-Salinas, Juan Salvador (Servicio de Radioterapia, Hospital de Especialidades) Ceja-Utrera, Francisco Javier (Servicio de Radioterapia, Hospital de Especialidades) Vazquez-Zamora, Victor Javier (Servicio de Radioterapia, Hospital de Especialidades) Vargas-Maldonado, Tomas (Banco de Sangre Hospital, Hospital de Especialidades) Reyes-Carmona, Sandra (Centro de Quimica, Instituto de Ciencias, Benemerita Universidad Autonoma de Puebla) Sosa-Jurado, Francisca (Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) Santos-Lopez, Gerardo (Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) Reyes-Leyva, Julio (Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) Vallejo-Ruiz, Veronica (Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) |
1 | Taniguchi A, Matsumoto K (1999). Epithelial-cell-specific transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1,4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene. Biochem Biophys Res Commun, 257, 516-22. DOI ScienceOn |
2 | Velazquez-Marquez N, Santos-Lopez G, Jimenez-Aranda L, Reyes-Leyva J, Vallejo-Ruiz V (2012). Sialyl Lewis x expression in cervical scrapes of premalignant lesions. J Biosci, 37, 1-6. DOI |
3 | Wang PH, Li YF, Juang CM, et al, (2002). Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis. Gynecol Oncol, 86, 45-52. DOI ScienceOn |
4 |
Wang PH, Lee WL, Lee YR, et al (2003). Enhaced expression of |
5 |
Wang X, Vertino A, Eddy RL, et al (1993). Chromosome mapping and organization of the human |
6 | Williams T, Tjian R (1991). Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev, 5, 670-82. DOI ScienceOn |
7 | Appenheimer MM, Huang RY, Chandrasekaran EV, et al. (2003). Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiol, 13, 591-600. DOI ScienceOn |
8 | Li GS, Zhu L, Zhang H, et al (2007). Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy. Hum Mutat, 10, 950-7. |
9 | Lopez-Morales D, Velazquez-Marquez N, Valenzuela O, et al (2009). Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. Invest Clin, 50, 45-53. |
10 |
Aasheim HC, Aas-Enh DA, Deggerdal A, et al (1993). Cell-specific expression of human beta galactoside |
11 | Lopez-Morales D, Reyes-Leyva J, Santos-Lopez G, Zenteno E, Vallejo-Ruiz V (2010). Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesions. Diagnos Pathol, 74, 1-5. |
12 | Mullan PB, Quinn JE, Harkin DP, (2006). The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene, 25, 5854-63. DOI ScienceOn |
13 | Roy A, Chakraborty S, (2005). Detection of cancer cervix by estimation of sialic acid. J Indian Med Assoc, 103, 589-90. |
14 | Sellers TA, Huang Y, Cunningham J, et al (2008). Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev, 17, 397-404. DOI ScienceOn |
15 | Arai M, Yamada K, Toyota T, et al (2006). Association between polymorphisms in the promoter region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia, Biol Psychiatry, 59, 652-9. DOI ScienceOn |
16 | Bull C, Boltje TJ, Wassink M, et al (2013). Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth. Mol Cancer Ther, 12, 1-12. DOI |
17 | Christie DR, Shaikh FM, Lucas JA IV, Lucas JA III, Bellis SL (2008). ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res, 1, 1-8. DOI ScienceOn |
18 | Hilger-Eversheim K, Moser M, Schorle H, Buettner R (2000). Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene, 260, 1-12. DOI ScienceOn |
19 |
Fukasawa T, Asao T, Yamauchi H, et al (2013). Associated expression of |
20 | Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, et al (2001). The human sialyltransferases family. Biochimie, 83, 727-37. DOI ScienceOn |
21 | Kitagawa H, Mattei MG, Paulson JC (1996). Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2, 3-sialyltransferase. J Biol Chem, 271, 931-8. DOI |
22 | Taniguchi A, Hioki M, Matsumoto K (2003). Transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1, 4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene in testis and ovary cell lines. Biochem Biophys Res Commun, 301, 764-8. DOI ScienceOn |
23 | Yu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A (2009). CD83 polymorphisms and cervical cancer risk. Gynecol Oncol, 114, 319-22. DOI ScienceOn |
24 | Zhang Z, Borecki I, Nguyen L, et al (2007). CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. Cancer Res, 67, 11202-8. DOI ScienceOn |
25 | Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD (2001). Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem, 276, 40755-60. DOI ScienceOn |
26 | Stanczuk GA, Sibanda EN, Perrey C, et al (2001). Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer, 94, 792-4. DOI ScienceOn |
27 | Taniguchi A, Matsumoto K, (1998). Down-regulation of human sialyltransferase gene expression during in vitro human keratinocyte cell line differentiation. Biochem Biophys Res Commun, 243, 177-83. DOI ScienceOn |
28 | Jiang P, Liu J, Zeng X, Li W, Tang J (2010). MDM2 Gene Promoter Polymorphism and Risk of Cervical Cancer in Chinese Population. Bioinformatics Biomed Eng, 4, 2-4. |
29 |
Milflores-Flores L, Millan-Perez L, Santos-Lopez G, Reyes-Leyva J, Vallejo-Ruiz V (2012). Characterization of P1 promoter activity of the |
![]() |